Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.23.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Apr. 02, 2023
Jan. 01, 2023
Current assets:    
Cash and cash equivalents $ 293,751 $ 322,851
Accounts receivable, net 21 170
Inventory 815 634
Deferred contract costs 800 800
Prepaid expenses and other current assets 5,857 5,193
Total current assets 301,244 329,648
Property and equipment, net 102,275 103,868
Operating lease, right-of-use assets 6,205 6,133
Other assets, non-current 881 937
Total assets 410,605 440,586
Current liabilities:    
Accounts payable 4,751 7,077
Accrued expenses 8,685 7,089
Accrued compensation 10,400 8,097
Deferred revenue 350 50
Other liabilities 916 716
Total current liabilities 25,102 23,029
Warrant liability 61,920 49,080
Operating lease liabilities, non-current 8,010 8,234
Deferred revenue, non-current 3,424 3,724
Other liabilities, non-current 38 92
Total liabilities 98,494 84,159
Commitments and Contingencies (Note 7)
Stockholders’ equity:    
Common stock, $0.0001 par value; authorized shares of 1,000,000,000; issued and outstanding shares of 158,089,463 and 157,461,802 as of April 2, 2023 and January 1, 2023, respectively 16 15
Preferred stock, $0.0001 par value; authorized shares of 10,000,000; no shares issued or outstanding as of April 2, 2023 and January 1, 2023, respectively 0 0
Additional paid-in-capital 770,472 741,186
Accumulated deficit (458,377) (384,774)
Total stockholders’ equity 312,111 356,427
Total liabilities and stockholders’ equity $ 410,605 $ 440,586